Real-World Effectiveness of Upadacitinib for Treatment of Rheumatoid Arthritis in Canadian Patients: Interim Results from the Prospective Observational CLOSE-UP Study.

MLA

Bessette, Louis, et al. “Real-World Effectiveness of Upadacitinib for Treatment of Rheumatoid Arthritis in Canadian Patients: Interim Results from the Prospective Observational CLOSE-UP Study.” Rheumatology & Therapy, vol. 11, no. 3, June 2024, pp. 563–82. EBSCOhost, https://doi.org/10.1007/s40744-024-00651-8.

APA

Bessette, L., Chan, J., Chow, A., Lisnevskaia, L., Richard, N., Fournier, P.-A., Liazoghli, D., Girard, T., & Haaland, D. (2024). Real-World Effectiveness of Upadacitinib for Treatment of Rheumatoid Arthritis in Canadian Patients: Interim Results from the Prospective Observational CLOSE-UP Study. Rheumatology & Therapy, 11(3), 563–582. https://doi.org/10.1007/s40744-024-00651-8

Chicago

Bessette, Louis, Jonathan Chan, Andrew Chow, Larissa Lisnevskaia, Nicolas Richard, Pierre-Andre Fournier, Dalinda Liazoghli, Tanya Girard, and Derek Haaland. 2024. “Real-World Effectiveness of Upadacitinib for Treatment of Rheumatoid Arthritis in Canadian Patients: Interim Results from the Prospective Observational CLOSE-UP Study.” Rheumatology & Therapy 11 (3): 563–82. doi:10.1007/s40744-024-00651-8.